
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Inspire Founder/CEO Brian Loew has announced a new initiative, the Inspire Research Accelerator, a program that aims to accelerate medical progress by enabling academic researchers around the world—at no cost—to collaborate with Inspire.
“The Accelerator’s goal is to enable scientific discovery by connecting researchers with patients, especially those affected by rare diseases,” Loew said.
The Accelerator will aim to help propel research in a variety of ways:
Read the full release,






